44 completed, 16 recruiting, 10 unknown, 9 terminated. 20 Phase 2, 13 Phase 3, 9 Not applicable, 6 Phase 1, 5 Phase 4.
Follow Pulmonary Aspergillosis: new trials by email Literature Review of Pulmonary Aspergillosis trials Research Report on Pulmonary Aspergillosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Real-World Effectiveness of Depemokimab in Allergic Bronchopulmonary Aspergillosis With Severe Eosinophilic Asthma Depemokimab - Allergic Bronchopulmonary Aspergillosis, ABPA | Not applicable | Not yet recruiting | Qianfoshan Hospital | 10 | 2026-11-01 | 2026-09-24 |
| Real-World Effectiveness of Tezepelumab in Allergic Bronchopulmonary Aspergillosis Tezepelumab - Allergic Bronchopulmonary Aspergillosis, Severe Asthma | Not applicable | Not yet recruiting | Qianfoshan Hospital | 10 | 2026-09-01 | 2026-08-11 |
| A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients With ABPA The patients were treated with bronchoscopic airway clearance and amphotericin B spraying - ABPA, Allergic Bronchopulmonary Aspergillosis | Recruiting | Qianfoshan Hospital | 44 | 2026-01-10 | 2026-01-23 | |
| Derivation and Validation of the Fungal Pneumonia Assessment and Likelihood Predictor Score FUNGAL-P Score Assessment - Pneumonia, Fungal Pneumonia | Recruiting | Azienda Ospedaliero-Universitaria Careggi | 400 | 2025-11-13 | 2026-07-02 | |
| Influenza A-associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit in China IPA and non-IPA groups - ICU, Invasive Pulmonary Aspergillosis | Completed | Jianfeng Xie | 542 | 2025-11-01 | 2026-01-09 | |
| Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis Fasenra - Allergic Bronchopulmonary Aspergillosis, Severe Asthma | Recruiting | Qianfoshan Hospital | 20 | 2025-09-01 | 2026-04-21 | |
| Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk Factors Liver Cirrhosis, Viral Pneumonia | Active not recruiting | Universitaire Ziekenhuizen KU Leuven | 450 | 2025-08-01 | 2026-03-04 | |
| Immune Status and Disease Control of Inflammatory Airway Diseases Airway Inflammation, Chronic Obstructive Pulmonary Disease (COPD) | Recruiting | First Affiliated Hospital of Ningbo University | 200 | 2025-08-01 | 2026-03-25 | |
| Fungal Status and Prognosis in ABPA ABPA, Allergic Bronchopulmonary Aspergillosis | Recruiting | Qianfoshan Hospital | 114 | 2025-07-01 | 2026-07-08 | |
| Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis Allergic Bronchopulmonary Aspergillosis (ABPA) | Recruiting | Qianfoshan Hospital | 140 | 2025-05-10 | 2025-07-04 | |
| iMagIng pulmonaRy Aspergillosis Using Gallium-68-dEferoxamine Radiopharmaceutical: gallium-68-deferoxamine ([68Ga]Ga-DFO-B) - Pulmonary Aspergillosis, Chronic Pulmonary Aspergillosis | Phase 2 | Completed | Radboud University Medical Center | 10 | 2025-05-01 | 2026-08-18 |
| PCR for Aspergillus Fumigatus in Blood and Bronchoalveolar Lavage Fluid for Monitoring Cases of Invasive Aspergillosis: What is Its Prognostic Value Invasive Pulmonary Aspergillosis | Recruiting | University Hospital, Strasbourg, France | 100 | 2025-03-17 | 2026-01-02 | |
| A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA Biologic Agent - ABPA, Biologics | Recruiting | Qianfoshan Hospital | 50 | 2025-01-31 | 2026-04-17 | |
| Multicenter Registration Study on Allergic Bronchopulmonary Aspergillosis Allergic Bronchopulmonary Aspergillosis | Not yet recruiting | Peking University Third Hospital | 300 | 2024-10-15 | 2024-10-16 | |
| Breath Analysis for the Detection of Invasive Fungal Infections Secondary electrospray ionization high-resolution mass spectrometry (SESI-HRMS) - Leukemia, Leukemia, Myeloid | Recruiting | University of Zurich | 130 | 2024-08-19 | 2025-04-10 | |
| Allergic Bronchopulmonary Aspergillosis Prescreening Study Allergic Bronchopulmonary Aspergillosis, Asthma | Withdrawn | Community Pharmacology Services Ltd | 2024-01-10 | 2024-01-16 | ||
| A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary Aspergillosis Prednisolone, Itraconazole - Allergic Bronchopulmonary Aspergillosis | Phase 3 | Recruiting | Post Graduate Institute of Medical Education and Research, Chandigarh | 300 | 2023-12-01 | 2025-02-28 |
| Incidence of Invasive Pulmonary Aspergillosis in Ventilator-associated Pneumonia Biological examinations performed on blood and BAL - Ventilator Associated Pneumonia, Pulmonary Aspergillosis Invasive | Completed | University Hospital, Lille | 263 | 2023-08-28 | 2025-12-26 | |
| Early Diagnosis of Invasive Lung Aspergillosis Next generation improvement of early invasive aspergillosis - Respiratory Infection, Invasive Pulmonary Aspergillosis | Recruiting | University Hospital Ostrava | 150 | 2023-05-31 | 2023-09-07 | |
| Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPA Itraconazole Powder, Placebo - ABPA | Phase 2 | Terminated | Pulmatrix Inc. | 8 | 2023-02-01 | 2024-04-02 |
Showing 20 of 89. Sign in to see all of them.
Invasive Pulmonary Aspergillosis (43) · Aspergillosis, Allergic Bronchopulmonary (42) · Mycoses (12) · Asthma (11) · Aspergillosis (8) · Cystic Fibrosis (6) · Invasive Fungal Infections (6) · Pulmonary Disease, Chronic Obstructive (5) · Influenza, Human (4) · Leukemia (3) · Pneumonia, Pneumocystis (3) · Respiratory Tract Infections (3) · Bronchiectasis (2) · COVID-19 (2)
Bacterial Infections and Mycoses (89) · Infections (89) · Lung Diseases (89) · Respiratory Tract Diseases (89) · Lung Diseases, Fungal (87) · Aspergillosis (81) · Mycoses (77) · Respiratory Tract Infections (52) · Immune System Diseases (46) · Hypersensitivity (43) · Hypersensitivity, Immediate (43) · Respiratory Hypersensitivity (43) · Invasive Fungal Infections (38) · Lung Diseases, Obstructive (15)
Voriconazole (8) · Itraconazole (6) · Glucocorticoids (4) · Prednisolone (4) · liposomal amphotericin B (4) · Amphotericin B (3) · Blood Specimen Collection (3) · Caspofungin (3) · Azoles (2) · Omalizumab (2) · Prednisone (2) · benralizumab (2) · ibrexafungerp (2) · Anidulafungin (1) · Biological Factors (1)
Post Graduate Institute of Medical Education and Research, Chandigarh (9) · Qianfoshan Hospital (9) · TFF Pharmaceuticals, Inc. (3) · Universitaire Ziekenhuizen KU Leuven (3) · Asan Medical Center (2) · GlaxoSmithKline (2) · Novartis Pharmaceuticals (2) · Pulmatrix Inc. (2) · Pulmocide Ltd (2) · Radboud University Medical Center (2) · Rambam Health Care Campus (2) · Scynexis, Inc. (2) · University of Pittsburgh (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Arkansas Children's Hospital Research Institute (1)
China (18) · United States (17) · France (16) · India (12) · Belgium (11) · United Kingdom (11) · Germany (10) · Netherlands (8) · Canada (7) · Australia (5) · Italy (5) · Spain (5) · Austria (4) · Israel (4) · South Korea (4)
Dale Christensen, PhD (2) · Jay K Kolls, MD (2) · Joost Wauters, MD, PhD (2) · Qian Qi (2) · Ritesh Agarwal, MD, DM (2) · Anders Krifors, M.D. (1) · Bart JA Rijnders, MD/PhD (1) · Brian Fisher (1) · Chiara Cattaneo (1) · Chris Cabell, MD (1) · Chuang Cai, doctor (1)
PMID 33027187, PMID 21729932, PMID 21854805, PMID 23359515, PMID 25203869, PMID 25927915, PMID 26302738, PMID 26585431, PMID 27011794, PMID 28530849, PMID 29331473, PMID 30049743, PMID 30561849, PMID 32407157, PMID 33293212, PMID 33549194, PMID 33744933, PMID 34739194, PMID 34764182, PMID 36005278, PMID 36565721, PMID 36739866, PMID 37541984, PMID 37676612, PMID 37897800, PMID 38383961, PMID 38387646, PMID 38461089, PMID 38954860, PMID 39900777, PMID 39918069, PMID 40203286, PMID 42845221
2017 (3), 2019 (3), P50HL084932 (2), 2016 (1), 2018 (1), 2023 (1), R01AI139032 (1)